Abstract CT307: Phase I, placebo-controlled, patient (pt)-blinded study to evaluate the effect of repeat oral dosing of the MEK inhibitor trametinib on cardiac repolarization in pt... by Rasco, Drew, Patnaik, Amita, Tolcher, Anthony W., Papadopoulos, Kyriakos P., Beeram, Muralidhar, Chambers, Glenda, Werner, Theresa L., Bauman, John W., Scheuber, Anita, Cox, Donna, Zhou, YanYan, Hamid, Mohammed, Schramek, Daniel, Criscitiello, Peggy, Sharma, Sunil

Get full text